Core Insights - Silo Pharma, Inc. has approved the purchase of up to $1 million in Bitcoin as a treasury reserve asset to diversify its holdings and provide a digital store of value with significant upside potential [1][2] - The CEO of Silo Pharma stated that this strategic decision aims to safeguard against inflation and optimize long-term shareholder value [2] Company Overview - Silo Pharma, Inc. is a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems [1] - The company addresses underserved conditions such as stress-induced psychiatric disorders, chronic pain, and central nervous system diseases [2] - Silo's portfolio includes innovative programs targeting PTSD, fibromyalgia, chronic pain, Alzheimer's disease, and multiple sclerosis, with research conducted in collaboration with leading universities and laboratories [2]

In this article GSBD Pedestrians walk past an Itau Unibanco Holding SA bank branch in Sao Paulo, Brazil. Patricia Monteiro/Bloomberg | Bloomberg | Getty Images Investors have been piling into emerging market bonds as Treasurys' long-held reputation as a safe haven took a beating following U.S. President Donald Trump's "reciprocal" tariffs. Emerging market local currency bond yields slid by 13 basis points between April 2 — when Trump announced the tariffs — and April 25, according to the most recent data pr ...